Annual long term liabilities:
$442.29M-$7.73M(-1.72%)Summary
- As of today (September 17, 2025), FOLD annual total long term liabilities is $442.29 million, with the most recent change of -$7.73 million (-1.72%) on December 31, 2024.
- During the last 3 years, FOLD annual long term liabilities has risen by +$423.21 million (+2218.55%).
- FOLD annual long term liabilities is now -1.72% below its all-time high of $450.02 million, reached on December 31, 2023.
Performance
FOLD Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$443.35M-$39.00K(-0.01%)Summary
- As of today (September 17, 2025), FOLD quarterly total long term liabilities is $443.35 million, with the most recent change of -$39.00 thousand (-0.01%) on June 30, 2025.
- Over the past year, FOLD quarterly long term liabilities has dropped by -$5.54 million (-1.23%).
- FOLD quarterly long term liabilities is now -22.50% below its all-time high of $572.07 million, reached on September 30, 2015.
Performance
FOLD quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
FOLD Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.7% | -1.2% |
| 3 y3 years | +2218.6% | +2228.2% |
| 5 y5 years | +954.7% | +1051.7% |
FOLD Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.7% | +2286.3% | -3.9% | +2292.1% |
| 5 y | 5-year | -1.7% | +2286.3% | -3.9% | +2339.9% |
| alltime | all time | -1.7% | >+9999.0% | -22.5% | >+9999.0% |
FOLD Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $443.35M(-0.0%) |
| Mar 2025 | - | $443.39M(+0.2%) |
| Dec 2024 | $442.29M(-1.7%) | $442.29M(-1.6%) |
| Sep 2024 | - | $449.59M(+0.2%) |
| Jun 2024 | - | $448.89M(-0.0%) |
| Mar 2024 | - | $448.99M(-0.2%) |
| Dec 2023 | $450.02M(+2328.1%) | $450.02M(-2.5%) |
| Sep 2023 | - | $461.39M(+0.5%) |
| Jun 2023 | - | $459.28M(-0.1%) |
| Mar 2023 | - | $459.56M(+2379.6%) |
| Dec 2022 | $18.53M(-2.8%) | $18.53M(-2.4%) |
| Sep 2022 | - | $18.98M(-0.3%) |
| Jun 2022 | - | $19.04M(+4.8%) |
| Mar 2022 | - | $18.17M(-4.7%) |
| Dec 2021 | $19.08M(-46.4%) | $19.08M(-28.6%) |
| Sep 2021 | - | $26.73M(+1.4%) |
| Jun 2021 | - | $26.35M(+4.3%) |
| Mar 2021 | - | $25.27M(-29.0%) |
| Dec 2020 | $35.61M(-15.1%) | $35.61M(+0.8%) |
| Sep 2020 | - | $35.34M(-8.2%) |
| Jun 2020 | - | $38.49M(-7.9%) |
| Mar 2020 | - | $41.78M(-0.4%) |
| Dec 2019 | $41.93M(+7.0%) | $41.93M(-0.2%) |
| Sep 2019 | - | $42.00M(-2.6%) |
| Jun 2019 | - | $43.10M(+2.0%) |
| Mar 2019 | - | $42.25M(+7.8%) |
| Dec 2018 | $39.17M(-2.0%) | $39.17M(-8.8%) |
| Sep 2018 | - | $42.95M(+3.3%) |
| Jun 2018 | - | $41.59M(+1.7%) |
| Mar 2018 | - | $40.91M(+2.4%) |
| Dec 2017 | $39.97M(-90.3%) | $39.97M(-3.2%) |
| Sep 2017 | - | $41.30M(-90.0%) |
| Jun 2017 | - | $412.22M(-0.9%) |
| Mar 2017 | - | $416.15M(+1.2%) |
| Dec 2016 | $411.27M(-7.6%) | $411.27M(-4.4%) |
| Sep 2016 | - | $429.99M(-0.9%) |
| Jun 2016 | - | $434.01M(-3.2%) |
| Mar 2016 | - | $448.34M(+0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $445.33M(+680.0%) | $445.33M(-22.2%) |
| Sep 2015 | - | $572.07M(+884.5%) |
| Jun 2015 | - | $58.11M(-0.5%) |
| Mar 2015 | - | $58.38M(+2.2%) |
| Dec 2014 | $57.09M(-0.1%) | $57.09M(+0.9%) |
| Sep 2014 | - | $56.58M(-1.5%) |
| Jun 2014 | - | $57.41M(-0.5%) |
| Mar 2014 | - | $57.69M(+0.9%) |
| Dec 2013 | $57.18M(+80.8%) | $57.18M(+68.1%) |
| Sep 2013 | - | $34.02M(+3.7%) |
| Jun 2013 | - | $32.81M(+2.9%) |
| Mar 2013 | - | $31.88M(+0.8%) |
| Dec 2012 | $31.63M(+51.0%) | $31.63M(+0.3%) |
| Sep 2012 | - | $31.52M(+52.9%) |
| Jun 2012 | - | $20.62M(-7.4%) |
| Mar 2012 | - | $22.26M(+6.3%) |
| Dec 2011 | $20.95M(-33.3%) | $20.95M(-10.7%) |
| Sep 2011 | - | $23.45M(-18.6%) |
| Jun 2011 | - | $28.80M(-12.3%) |
| Mar 2011 | - | $32.85M(+4.6%) |
| Dec 2010 | $31.39M(+1239.4%) | $31.39M(+512.8%) |
| Sep 2010 | - | $5.12M(+51.7%) |
| Jun 2010 | - | $3.38M(-33.8%) |
| Mar 2010 | - | $5.11M(+117.8%) |
| Dec 2009 | $2.34M(-94.7%) | $2.34M(-94.8%) |
| Sep 2009 | - | $44.65M(-0.3%) |
| Jun 2009 | - | $44.80M(+2.8%) |
| Mar 2009 | - | $43.56M(-1.8%) |
| Dec 2008 | $44.35M(-7.6%) | $44.35M(-1.9%) |
| Sep 2008 | - | $45.21M(-2.0%) |
| Jun 2008 | - | $46.12M(-2.0%) |
| Mar 2008 | - | $47.04M(-2.0%) |
| Dec 2007 | $48.01M(-62.2%) | $48.01M(+2951.9%) |
| Sep 2007 | - | $1.57M(-19.5%) |
| Jun 2007 | - | $1.95M(-98.7%) |
| Mar 2007 | - | $150.76M(+18.8%) |
| Dec 2006 | $126.95M(+105.1%) | $126.95M(+105.1%) |
| Dec 2005 | $61.91M(>+9900.0%) | $61.91M |
| Dec 2004 | $0.00 | - |
FAQ
- What is Amicus Therapeutics, Inc. annual total long term liabilities?
- What is the all time high annual long term liabilities for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. annual long term liabilities year-on-year change?
- What is Amicus Therapeutics, Inc. quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. quarterly long term liabilities year-on-year change?
What is Amicus Therapeutics, Inc. annual total long term liabilities?
The current annual long term liabilities of FOLD is $442.29M
What is the all time high annual long term liabilities for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high annual total long term liabilities is $450.02M
What is Amicus Therapeutics, Inc. annual long term liabilities year-on-year change?
Over the past year, FOLD annual total long term liabilities has changed by -$7.73M (-1.72%)
What is Amicus Therapeutics, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of FOLD is $443.35M
What is the all time high quarterly long term liabilities for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high quarterly total long term liabilities is $572.07M
What is Amicus Therapeutics, Inc. quarterly long term liabilities year-on-year change?
Over the past year, FOLD quarterly total long term liabilities has changed by -$5.54M (-1.23%)